Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study

Meletios A. Dimopoulos; Sagar Lonial; Darrell White; Philippe Moreau; Katja Weisel; Jesus San-Miguel; Ofer Shpilberg; Sebastian Grosicki; Ivan Špička; Adam Walter-Croneck; Hila Magen; Maria Victoria Mateos; Andrew Belch; Donna Reece; Meral Beksac; Andrew Spencer; Heather Oakervee; Robert Z. Orlowski; Masafumi Taniwaki; Christoph Röllig; Hermann Einsele; Morio Matsumoto; Ka Lung Wu; Kenneth C. Anderson; Ying Ming Jou; Alex Ganetsky; Anil K. Singhal; Paul G. Richardson

doi:10.1038/s41408-020-00357-4

Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study

Meletios A. Dimopoulos, Sagar Lonial, Darrell White, Philippe Moreau, Katja Weisel, Jesus San-Miguel, Ofer Shpilberg, Sebastian Grosicki, Ivan Špička, Adam Walter-Croneck, Hila Magen, Maria Victoria Mateos, Andrew Belch, Donna Reece, Meral Beksac, Andrew Spencer, Heather Oakervee, Robert Z. Orlowski, Masafumi Taniwaki, Christoph RölligHermann Einsele, Morio Matsumoto, Ka Lung Wu, Kenneth C. Anderson, Ying Ming Jou, Alex Ganetsky, Anil K. Singhal, Paul G. Richardson

科研成果: 期刊稿件 › 文章 › 同行评审

104 引用（Scopus）

源语言	英语
文章编号	91
期刊	Blood Cancer Journal
卷	10
期	9
DOI	https://doi.org/10.1038/s41408-020-00357-4
出版状态	已出版 - 9月 1 2020
已对外发布	是

!!!ASJC Scopus Subject Areas

血液学
肿瘤学

访问文件

10.1038/s41408-020-00357-4

其它文件与链接

引用此

Dimopoulos, M. A., Lonial, S., White, D., Moreau, P., Weisel, K., San-Miguel, J., Shpilberg, O., Grosicki, S., Špička, I., Walter-Croneck, A., Magen, H., Mateos, M. V., Belch, A., Reece, D., Beksac, M., Spencer, A., Oakervee, H., Orlowski, R. Z., Taniwaki, M., ... Richardson, P. G. (2020). Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study. Blood Cancer Journal, 10(9), 文章 91. https://doi.org/10.1038/s41408-020-00357-4

Dimopoulos, MA, Lonial, S, White, D, Moreau, P, Weisel, K, San-Miguel, J, Shpilberg, O, Grosicki, S, Špička, I, Walter-Croneck, A, Magen, H, Mateos, MV, Belch, A, Reece, D, Beksac, M, Spencer, A, Oakervee, H, Orlowski, RZ, Taniwaki, M, Röllig, C, Einsele, H, Matsumoto, M, Wu, KL, Anderson, KC, Jou, YM, Ganetsky, A, Singhal, AK & Richardson, PG 2020, 'Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study', Blood Cancer Journal, 卷 10, 号码 9, 91. https://doi.org/10.1038/s41408-020-00357-4

@article{fb26eb9b3fe1410b8c8c35b9dd5541e5,

title = "Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study",

author = "Dimopoulos, {Meletios A.} and Sagar Lonial and Darrell White and Philippe Moreau and Katja Weisel and Jesus San-Miguel and Ofer Shpilberg and Sebastian Grosicki and Ivan {\v S}pi{\v c}ka and Adam Walter-Croneck and Hila Magen and Mateos, {Maria Victoria} and Andrew Belch and Donna Reece and Meral Beksac and Andrew Spencer and Heather Oakervee and Orlowski, {Robert Z.} and Masafumi Taniwaki and Christoph R{\"o}llig and Hermann Einsele and Morio Matsumoto and Wu, {Ka Lung} and Anderson, {Kenneth C.} and Jou, {Ying Ming} and Alex Ganetsky and Singhal, {Anil K.} and Richardson, {Paul G.}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = sep,

day = "1",

doi = "10.1038/s41408-020-00357-4",

language = "English",

volume = "10",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Elotuzumab, lenalidomide, and dexamethasone in RRMM

T2 - final overall survival results from the phase 3 randomized ELOQUENT-2 study

AU - Dimopoulos, Meletios A.

AU - Lonial, Sagar

AU - White, Darrell

AU - Moreau, Philippe

AU - Weisel, Katja

AU - San-Miguel, Jesus

AU - Shpilberg, Ofer

AU - Grosicki, Sebastian

AU - Špička, Ivan

AU - Walter-Croneck, Adam

AU - Magen, Hila

AU - Mateos, Maria Victoria

AU - Belch, Andrew

AU - Reece, Donna

AU - Beksac, Meral

AU - Spencer, Andrew

AU - Oakervee, Heather

AU - Orlowski, Robert Z.

AU - Taniwaki, Masafumi

AU - Röllig, Christoph

AU - Einsele, Hermann

AU - Matsumoto, Morio

AU - Wu, Ka Lung

AU - Anderson, Kenneth C.

AU - Jou, Ying Ming

AU - Ganetsky, Alex

AU - Singhal, Anil K.

AU - Richardson, Paul G.

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85090272726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090272726&partnerID=8YFLogxK

U2 - 10.1038/s41408-020-00357-4

DO - 10.1038/s41408-020-00357-4

M3 - Article

C2 - 32887873

AN - SCOPUS:85090272726

SN - 2044-5385

VL - 10

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 9

M1 - 91

ER -

Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此